Latest News and Press Releases
Want to stay updated on the latest news?
-
Details from the Promimic announcement follow: Magnus Larsson has a solid background in Sales and Marketing, having held a number of leadership positions in the international dental...
-
About Aprea Therapeutics AB Aprea Therapeutics AB is a Boston, Massachusetts- and Stockholm, Sweden-based biopharmaceutical company focused on the discovery and development of novel anticancer...
-
Details from the Dilafor press release follow: Tafoxiparin is in clinical development as a new treatment designed to decrease the incidence of protracted labor (i.e labor that lasts more...
-
Details from the Dilafor press release follow: Tafoxiparin is in clinical development as a new treatment designed to decrease the incidence of protracted labor both after induction of...
-
Details from the Modus Therapeutics press release follow: The poster entitled: Sevuparin Blocks Sickle Blood Cell Adhesion and Sickle-Leukocyte Rolling on Immobilized L-Selectin in a Dose...
-
Jim Van heusden, CEO, comments: “During the third quarter 2016, Karolinska Development saw several of its portfolio companies secure new funds to finance the progression of their businesses toward...
-
Jim Van heusden, CEO, kommenterar: “Under tredje kvartalet 2016 har flera av Karolinska Developments portföljbolag säkrat ny finansiering för att utveckla verksamheten mot sina definierade...
-
Details from the Umecrine Cognition press release follow: Hepatic encephalopathy (HE) is a serious brain disorder and one of the primary complications in acute and chronic liver disease....
-
Vänligen ring in på något av följande telefonnummer några minuter före telefonkonferensens start: Från Sverige: +46 (0) 8 505 564 74 Från USA: +1 855 753 22 30 Från Storbritannien: +44...
-
Vänligen ring in på något av följande telefonnummer några minuter före telefonkonferensens start: Från Sverige: +46 (0) 8 505 564 74 Från USA: +1 855 753 22 30 Från Storbritannien: +44...